Table 8.

Composition of the formulations prepared for further investigation.

SNEDDS Formulation Code	DFX Amount (mg/mL)	Peceol (w/w,%)	Kolliphor EL (w/w,%)	Transcutol HP (w/w,%)
P1-50			45	45
P2-50			30	60
P3-50			60	30
P4-50	50	10	36	54
P5-50			67.5	22.5
P6-50			54	36
P7-50			72	18
P1-45			45	45
P2-45			30	60
P3-45			60	30
P4-45	45	10	36	54
P5-45			67.5	225
P6-45			54	36
P7-45			72	18
P1-40			45	45
P2-40			30	60
P3-40			60	30
P4-40	40	10	36	54
P5-40			67.5	22.5
P6-40			54	36
P7-40			72	18